ElectroPhysiology Frontiers S.p.A. is a MedTech startup launched in 2019 that specializes in the development of an innovative catheter ablation system. The company's primary focus is on creating a user-friendly "single shot" ablation system that aims to deliver more sustainable ablations, ultimately reducing the recurrence rate of Atrial Fibrillation (AFib) following pulmonary vein ablation (PVI). Operating within the Design, Manufacturing, and Medical Devices sectors, ElectroPhysiology Frontiers is poised to make a significant impact in the field of medical technology. The company's groundbreaking approach to addressing an unmet need in cardiac care positions it as a promising investment opportunity for venture capitalists seeking to contribute to the advancement of healthcare technology.
There is no investment information
No recent news or press coverage available for ElectroPhysiology Frontiers S.p.A..
We care about your data, and we'd love to use cookies make your experience better.
